Clinical and research tests for C0268634 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First< Prev

Page 1 of 2

Results: 1 to 20 of 21

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
Postmortem Screening, Bile and Blood Spot Mayo Clinic Laboratories Mayo Clinic United States	3	1	A Analyte
Fatty Acid Oxidation Probe Assay, Fibroblast Culture Mayo Clinic Laboratories Mayo Clinic United States	7	1	A Analyte
PGmax™ - Comprehensive Inherited Metabolic Disorders and Mitochondrial Disorders (Nuclear Genes only) Panel PreventionGenetics, part of Exact Sciences United States	10	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Fatty Acid Oxidation Gene Panel Mayo Clinic Laboratories Mayo Clinic United States	2	44	D Deletion/duplication analysis C Sequence analysis of the entire coding region
urine organic acid profile, qualitative IU Genetic Testing Laboratories Indiana University School of Medicine United States	3	1	A Analyte
Acylcarnitine profile, plasma, quantitative IU Genetic Testing Laboratories Indiana University School of Medicine United States	3	1	A Analyte
PGmax™ - Neonatal Crisis Panel PreventionGenetics, part of Exact Sciences United States	21	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Organic Acid Analysis, Urine Biochemical Genetics Laboratory LabCorp United States	4	1	A Analyte
Acylcarnitine Profile, Quantitative, Plasma Biochemical Genetics Laboratory LabCorp United States	3	1	A Analyte
ACADM Invitae United States	2	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Fatty Acid Oxidation Syndrome Panel Blueprint Genetics Finland	1	26	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Fatty Acid Oxidation Deficiency Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University United States	4	22	C Sequence analysis of the entire coding region
Invitae Elevated C4 Panel Invitae United States	5	4	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Elevated C14 and C14:1 (VLCAD deficiency) Test Invitae United States	2	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Elevated C5 Panel Invitae United States	4	2	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Elevated C16-OH, C16:1-OH, C18-OH and C18:1-OH Panel Invitae United States	3	2	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Elevated C0/(C16+C18) Test Invitae United States	2	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Elevated C16, C16:1, C18, and C18:1 Panel Invitae United States	6	2	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Low C0 Test Invitae United States	2	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Carnitine Biochemical Genetics Laboratory University of California San Diego United States	1	1	A Analyte

<< First< Prev

Page 1 of 2

Results: 1 to 20 of 21

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.